Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEX mGM-CSF

Keegan Cooke,Karen Fitzgerald,Becky Yang, Petia Mitchell,Juan Estrada,Beltran Pedro,Achim K Moesta

Journal for ImmunoTherapy of Cancer（2015）

引用 2|浏览11

暂无评分

摘要

Meeting abstracts Talimogene laherparepvec, an investigational oncolytic immunotherapy, is a modified herpes simplex virus type-1 (HSV-1) designed to selectively replicate in tumors and to initiate a systemic immune response to target cancer cells. Intralesional administration of talimogene

查看译文

关键词

Drain Lymph Node,Tumor Drain Lymph Node,Induce Tumor Regression,Talimogene Laherparepvec,Intralesional Administration

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要